PozLab is a contract development and manufacturing organization offering expert drug product development services and small pilot plant capabilities, including analytical, formulation, and process development competencies, followed by microbiological testing. PozLab holds a GMP license for the manufacture of medical and investigational products.
Since May 2024, PozLab is a part of Selvita Group.
Company Details
- Employees
- 66
- Founded
- -
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- pozlab.pl
- Keywords
- Microbiological Laboratory, Technologies and Processes, GMP Pilot Plant, Stability Tests, Pharmaceutical Analysis, Hot Melt Extrusion, Spray Drying, Preclinical development, Formulation development, Investigational Medicinal Product, Contract Development, Clinical supply, Quality Control, UHPLC-MS Q-TOF, Analytical development, Pharmaceutical development.
Pozlab Questions
Pozlab's website is pozlab.pl
Pozlab's LinkedIn profile is https://pl.linkedin.com/company/pozlab
Pozlab has
66 employees.
View email and phone details for 66
employees at Pozlab.
Pozlab's industry is
Pharmaceutical Manufacturing
Pozlab's top competitors are
Selvita,
Herbapol Poznań S.a.,
Adamed Pharma,
Celon Pharma S.a.,
Curtis Health Caps,
Polpharma,
Delpharm Poznan,
Grupa Neuca,
Biofarm Poland,
Gsk.
Pozlab's categories are Pharmaceutical Manufacturing
Pozlab's founding year is 2010
